Surveillance for Severe Acute Respiratory Infections Among Hospitalized Subjects from 2015/2016 to 2019/2020 Seasons in Tuscany, Italy

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2021 Apr 30

PMID 33917106

Authors

Ilaria Manini

Andrea Camarri

Serena Marchi

Claudia Maria Trombetta

Ilaria Vicenti

Filippo Dragoni

Giacomo Lazzeri

Giovanni Bova

Emanuele Montomoli

Pier Leopoldo Capecchi

Affiliations

Soon will be listed here.

Abstract

In Italy, the influenza season lasts from October until April of the following year. Influenza A and B viruses are the two viral types that cocirculate during seasonal epidemics and are the main causes of respiratory infections. We analyzed influenza A and B viruses in samples from hospitalized patients at Le Scotte University Hospital in Siena (Central Italy). From 2015 to 2020, 182 patients with Severe Acute Respiratory Infections were enrolled. Oropharyngeal swabs were collected from patients and tested by means of reverse transcriptase-polymerase chain reaction to identify influenza A(H3N2), A(H1N1)pdm09 and B. Epidemiological and virological surveillance remain an essential tool for monitoring circulating viruses and possible mismatches with seasonal vaccine strains, and provide information that can be used to improve the composition of influenza vaccines.

References

Stuurman A, Bollaerts K, Alexandridou M, Biccler J, Diez Domingo J, Nohynek H . Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19. Vaccine. 2020; 38(41):6455-6463. DOI: 10.1016/j.vaccine.2020.07.063. View

Rondy M, Kissling E, Emborg H, Gherasim A, Pebody R, Trebbien R . Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill. 2018; 23(9). PMC: 5840921. DOI: 10.2807/1560-7917.ES.2018.23.9.18-00086. View

Rizzo C, Gesualdo F, Loconsole D, Pandolfi E, Bella A, Orsi A . Moderate Vaccine Effectiveness against Severe Acute Respiratory Infection Caused by A(H1N1)pdm09 Influenza Virus and No Effectiveness against A(H3N2) Influenza Virus in the 2018/2019 Season in Italy. Vaccines (Basel). 2020; 8(3). PMC: 7564262. DOI: 10.3390/vaccines8030427. View

Macias A, McElhaney J, Chaves S, Nealon J, Nunes M, Samson S . The disease burden of influenza beyond respiratory illness. Vaccine. 2020; 39 Suppl 1:A6-A14. PMC: 7545338. DOI: 10.1016/j.vaccine.2020.09.048. View

Melidou A, Broberg E . Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation.... Vaccine. 2017; 35(37):4828-4835. DOI: 10.1016/j.vaccine.2017.07.057. View

Rondy M, Larrauri A, Casado I, Alfonsi V, Pitigoi D, Launay O . 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project. Euro Surveill. 2017; 22(30). PMC: 5553054. DOI: 10.2807/1560-7917.ES.2017.22.30.30580. View

Rondy M, Gherasim A, Casado I, Launay O, Rizzo C, Pitigoi D . Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season. Euro Surveill. 2017; 22(41). PMC: 5710120. DOI: 10.2807/1560-7917.ES.2017.22.41.17-00645. View

Caini S, Kroneman M, Wiegers T, El Guerche-Seblain C, Paget J . Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: A systematic literature review. Influenza Other Respir Viruses. 2018; 12(6):780-792. PMC: 6185883. DOI: 10.1111/irv.12575. View

Adlhoch C, Snacken R, Melidou A, Ionescu S, Penttinen P . Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively. Euro Surveill. 2018; 23(13). PMC: 5883452. DOI: 10.2807/1560-7917.ES.2018.23.13.18-00146. View

10.

Costantino C, Restivo V, Amodio E, Colomba G, Vitale F, Tramuto F . A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy). Vaccine. 2019; 37(39):5812-5816. DOI: 10.1016/j.vaccine.2019.08.014. View

11.

Bellino S, Bella A, Puzelli S, Di Martino A, Facchini M, Punzo O . Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy. Expert Rev Vaccines. 2019; 18(11):1201-1209. DOI: 10.1080/14760584.2019.1688151. View

12.

Trombetta C, Marchi S, Manini I, Kistner O, Li F, Piu P . Influenza D Virus: Serological Evidence in the Italian Population from 2005 to 2017. Viruses. 2020; 12(1). PMC: 7019439. DOI: 10.3390/v12010030. View

13.

Fitzner J, Qasmieh S, Mounts A, Alexander B, Besselaar T, Briand S . Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018; 96(2):122-128. PMC: 5791775. DOI: 10.2471/BLT.17.194514. View

14.

Bella A, Gesualdo F, Orsi A, Arcuri C, Chironna M, Loconsole D . Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season. Expert Rev Vaccines. 2019; 18(6):671-679. DOI: 10.1080/14760584.2019.1627206. View

15.

Gasparini R, Bonanni P, Amicizia D, Bella A, Donatelli I, Cristina M . Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage. Hum Vaccin Immunother. 2013; 9(3):561-7. PMC: 3891712. DOI: 10.4161/hv.23235. View

16.

Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O . Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe. Euro Surveill. 2016; 21(13). DOI: 10.2807/1560-7917.ES.2016.21.13.30184. View

17.

Kissling E, Rose A, Emborg H, Gherasim A, Pebody R, Pozo F . Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill. 2019; 24(8). PMC: 6446950. DOI: 10.2807/1560-7917.ES.2019.24.1900121. View